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Ethylene diamineAbstract The complex tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate [Co(en)3]
Cl(C2O4)Æ3H2O crystallizes in the monoclinic space group C2/c with the following unit cell param-
eters a= 19.9318 (13), b= 9.3344 (4), c= 19.0881 (13) A˚ b= 96.846(3), Z= 8. The crystal
structure was solved by direct methods and reﬁned by full matrix least squares procedures to a ﬁnal
R value of 0.0314 for 4330 observed reﬂections. The reported cobalt complex is six co-ordinated
through amine nitrogen with distorted octahedral geometry. There are uncoordinated chloride
and oxalate ions along with the water molecules. In-vitro antimicrobial activity was studied against
various test organisms and found to be good. From in-vitro cytotoxic activity of the synthesized
complex, the IC50 value was found to be 55.85 lg/ml.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Metals have been used in the treatment of diseases of humans
since ancient times. The Chinese were using elemental gold for
the treatment of diseases, a practice known as chrysotherapy,
as far back as 2500 BC (Merchant, 1998). Only a small numberof cobalt(III) complexes are known to have biochemical roles.
Vitamin B12 is a cobaloxime, a cobalt complex containing a gly-
oxime ligand, and is one of the rare examples of a naturally
occurring organometallic complex i.e. possessing a metal car-
bon bond. A large number of reports on the antibacterial prop-
erties of cobalt complexes have appeared in the literature, with
Co(II) complexes being the most studied, presumably due to
their aqueous stability, availability, and ease of synthesis. How-
ever a number of examples of stable Co(III) complexes have
also been reported. Reports on the antibacterial properties of
cobalt(III) complexes frequently emphasize the increased effec-
tiveness of cobalt ion coordination to a particular ligand when
compared to the free ligand itself. Chelation of a bulky ligand to
a metal cation reduces the polarity of the ion due to ligandtris(eth-
2 S. Jone Kirubavathy et al.orbital overlap with the metal orbitals resulting in a delocaliza-
tion of positive charge. An increase in lipophilicity of a metal
complex enhances bacterial cell membrane penetration and
blocking of metal binding sites on enzymes. Nagababu and
co-workers screened a large number of bis(ethylenedia-
mine)cobalt(III) cations against gram-positive and gram-nega-
tive bacteria Escherichia coli, Salmonella typhimurium, Proteus
vulgaris, Pseudomonas aeruginosa, Staphylococcus aureus,
Streptococcus faecalis, Bacillus subtilis (Nagababu et al., 2006).
Cobalt complexes have attracted a great deal of attention
amongst the scientiﬁc community due to their therapeutic uses
as tumour imaging agent, antitumour, transport protein trans-
ferrin (Tf), antiviral, antiparasitic, antithrombolytic, enzymatic
therapeutics, anti-inﬂammatory activities and as metabolic
modiﬁer (Smith, 2005; Liang et al., 2004; Maccari et al.,
2004; Unitt et al., 1999; Mishra et al., 2008). The aim of our
present work is to co-ordinate the metal ion with ethylenedia-
mine and oxalic acid and study their pharmacological action.
2. Materials and methods
All reagents, ethylenediamine, oxalic acid and cobalt(II)chlo-
ride were purchased from Sigma Aldrich, India.
2.1. Physical measurements
Micro analytical data of the compounds were recorded in the
Elementar Vario EL III CHN analyser. The FT-IR spectra of
the samples were recorded on a Shimadzu spectrophotometer
in 4000-400 cm1. The UV–Visible spectra were recorded on
an Elico SL 159 UV–Vis spectrophotometer. Magnetic suscep-
tibility measurements of the complexes were carried out by
Guoy balance using copper sulphate as the calibrant. The
molar conductance of the complex was measured using a sys-
tronics conductivity bridge at room temperature in DMSO
solution. The antimicrobial activities of the ligand and its com-
plex were carried out by the disc diffusion method. The ther-
mal behaviour of Co(III) complex was studied using Perkin
Elmer STA 6000 thermoanalyser.
2.2. Synthesis of tris ethylenediamine cobalt(III)chloride
oxalate trihydrate
An ethanolic solution of ethylenediamine (0.03 mol, 1.8 ml),
oxalic acid (0.01 mol, 0.63 g) and cobaltous chloride
(Canpolat et al., 2004) CoCl2Æ6H2O (0.01 mol, 2.37 g) was
reﬂuxed for 2 h in the presence of aq.NH3 on a water bath.
On cooling, the orange colour crystals obtained were ﬁltered,
washed with ethanol and dried. The crude product was recrys-
tallized by the slow evaporation method using methanol as sol-
vent. After 15 days diamond shaped single crystals were
harvested. Yield: 67%. Anal. Calcd for CoC8H30N6O7Cl;
(%): C, 23.03; H, 7.19; N, 20.15. Found (%): C, 23.02; H,
7.19; N, 20.16 (see Scheme 1).
2.3. Determination of X-ray crystal structure of Co(III)
complex
X-ray diffraction for the complex tris ethylenediamine
cobalt(III)chloride oxalate trihydrate was made on a BrukerPlease cite this article in press as: Jone Kirubavathy, S. et al., Synthesis, characterizat
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monochromated Mo-Ka radiation (k= 0.71073 ). The crystal
structure was solved by direct methods. Structure reﬁnements
were performed by full matrix least squares procedures using
SHELXL-97 on F2. The crystal data and structural reﬁnement
parameters are summarized in Table 1.
2.4. Antimicrobial activity
The antibacterial activity of the metal complex was screened for
grampositive bacteria and gram negative bacteria namelyBacil-
lus subtilis, Staphylococcus aureus, Escherichia coli, Klebsiella
pneumoniae respectively by the disc diffusion method using agar
nutrient as the medium. The antifungal activities were screened
for the organisms Mesodinium rubrum, Aspergillus niger and
Candida albicans by the disc diffusion method cultured on
potato dextrose agar as medium. The plate was incubated
24 h for bacteria and 72 h for fungi. During this period, the test
solution diffused and the growth of the inoculated microorgan-
isms was affected. An inhibition zone was developed, at which
the concentration was noted (Chohan et al., 2005).
2.5. Cytotoxic activity
The cobalt complex was checked with its cytotoxic activity
(MTT assay) against MCF-7 which was obtained from
National Centre for Cell Science, Pune. The cells were grown
and maintained at 37 C, 5% CO2, 95% air and 100% humid-
ity. After 48 h of incubation, MTT was added and incubated at
37 C for another 4 h. The medium with MTT was ﬂicked off
and measured the absorbance at 570 nm using micro plate
reader. The percentage cell viability was calculated with
respect to the control.
3. Spectral discussion
3.1. General properties of
tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate
The analytical data of the complex are in good agreement with
the experimental values. The complex is soluble in common
polar solvents but readily soluble in DMF and DMSO to give
stable solutions at room temperature. In the solid state, the
Co(III) complex is fairly stable in air allowing physical measure-
ments. The molar conductance of Co(III) complex is
74 Smol1 cm1 showing their electrolytic nature (Geary, 1971).
3.2. FT-IR spectral studies of the ligand and
tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate
The FT-IR spectral data provide valuable information regard-
ing the nature of the functional group attached to the metal
atom. In the ethylenediamine cobalt complex, two bands
appeared at 3195 and 3074 cm1 which correspond to the –
NH2 group in the complex (Thankamony and Mohanan,
2007; Raman et al., 2004). A band at 1744 cm1 is attributed
to the >C‚O vibration in the oxalate group. From IR, the
exact co-ordination site for this complex is amino nitrogen
which was further conﬁrmed by single crystal XRD studies.
The IR spectrum of the complex is given in Fig. 1.ion, single crystal XRD, in vitro antimicrobial and cytotoxicity study of tris(eth-
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Scheme 1 Synthesis of tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate.
Table 1 Crystal data and structure reﬁnement for
[Co(en)3]Cl(C2O4)Æ3H2O.
Empirical formula CoC8H30N6O7Cl
Formula weight 416.76
Temperature 296(2) K
Wavelength 0.71073 A
Crystal system, space group Monoclinic, C2/c
Unit cell dimensions a= 19.9318(13) A˚ alpha = 90
b= 9.3344(4) A˚ beta = 96.846(3)
c= 19.0881(13) A˚ gamma= 90
Volume 3526.0(4) A3
Z, Calculated density 8, 1.570 Mg/m3
Absorption coeﬃcient 1.167 mm1
F(000) 1760
Crystal size 0.40 · 0.35 · 0.30 mm
Theta range for data collection 2.15 to 28.24
Limiting indices 26 6 h 6 26, 12
6 k 6 11, 25 6 l 6 19
Reﬂections collected/unique 13,098/4330 [R(int) = 0.0218]
Completeness to theta 28.24 99.0%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7209 and 0.6525
Reﬁnement method Full-matrix least-squares on F2
Data/restraints/parameters 4330/9/281
Goodness-of-ﬁt on F2 1.110
Final R indices [I> 2rI] R1 = 0.0314, wR2 = 0.0886
R indices (all data) R1 = 0.0394, wR2 = 0.0999
Extinction coeﬃcient 0.0007(2)
Largest diﬀ. peak and hole 0.797 and 0.381 e A3
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cobalt(III)chloride oxalate trihydrate
The electronic absorption spectrum of the complex was
recorded using solvent DMF at 25 C. The electronic spectral
data are in relevance with proposed geometry of the complex.
The electronic spectra of Co(III) complex display bands are at
285, 350 and 400 nm (Fig. 2). The absorptions around 280–
360 nm are ascribed to metal to ligand charge transfer. The
absorption at 400 nm may be assigned to 4T1g(F)ﬁ 4A2g(F).
These are similar to those reported for other six co-ordinated
Co(III) complexes (Raman et al., 2009; Howlader and Islam,
2007; Lever and Mantovani, 1971; Lever, 1968; Guoy and
Ballhausen, 1963; Ababei et al., 2011).
3.4. Thermal behaviour (TGA/DTA) of
tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate
The thermogravimetric analysis gives information about the
thermal stability of the complex and suggests a general schemePlease cite this article in press as: Jone Kirubavathy, S. et al., Synthesis, characterizat
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investigation, heating rates were suitably controlled at
10 C min1 under nitrogen atmosphere and the weight loss
was measured from the ambient temperature up to 800 C.
The thermogram of the Co(III) complex shows two decompo-
sition steps within the temperature range 35-500 C
corresponds to the loss of water molecule of hydration, chlo-
rine and carbon dioxide gases with a mass loss of 34% (Cald:
32.02%) accompanied by two exothermic peak with
tmax = 129.02 and 371.89 C on the DTA curve, may be
attributed to the removal of co-ordinated water and the non-
co-ordinated part of the ligand. The subsequent steps
(>500 C) correspond to the removal of the organic part of
the ligands, leaving metal oxide as a residue. The overall
weight loss amounts to 65% (Cald: 62.6%). This mass loss cor-
responds to the pyrolysis of the ligand molecules leaving
Co2O3 as residue. An exothermic peak with tmax = 551 C
on the DTA curve was observed for this step. The thermogram
of the Co(III) complex is depicted in Fig. 3.
3.5. Single crystal XRD data of
tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate
A single crystal of the title complex measuring
0.40 · 0.35 · 0.30 mm was picked up for X-ray intensity data
collection on a Bruker Apex Area II CCD detector. A total
number of 13,098 reﬂections were collected out of which
4330 were treated as observed (I> 2rI). Data were corrected
for absorption factor. The ﬁnal reﬁnement cycle yielded an
R factor of 0.0314 [wR2 = 0.0886] for 4330 observed
reﬂections. The CIF for this structure has been deposited at
Cambridge Crystal Data Centre (CCDC 929136). The crystal-
lographic data are summarized in Table 1. The bond lengths
and bond angles are given in Table 2. An ORTEP view of
the complex is shown in Fig. 4.
In the cobalt complex three ethylenediamine molecules are
bound to the Co(III) ion through nitrogen with the bond
lengths Co(1)–N(1), Co(1)–N(2), Co(1)–N(3), Co(1)–N(4),
Co(1)–N(5), Co(1)–N(6) as 1.9650(16), 1.9615(15), 1.9613(15),
1.9655(16), 1.9538(15) and 1.9623(15) A˚ respectively. These
are the new bonds formed while complexation. The bond angles
of N(1)–Co(1)–N(2), N(3)–Co(1)–N(4) and N(5)–Co(1)–N(6)
are 85.17(7), 85.78(7) and 85.52(7) respectively. The counter
ion in most of the ethylenediamine complexes is chloride ion
but in this complex the counter ions are chloride and oxalate
which is proved from the bond lengths C(7)–C(8), C(7)–O(2),
C(7)–O(3), C(8)–O(4), C(8)–O(5) as 1.563(2), 1.254(2),
1.245(2), 1.252(2), 1.245(2) respectively. A packing view of
the complex in the unit cell is shown in Fig. 5.ion, single crystal XRD, in vitro antimicrobial and cytotoxicity study of tris(eth-
2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.013
Figure 1 IR Spectrum of [Co(en)3]Cl(C2O4)Æ3H2O complex.
Figure 2 Electronic spectrum of [Co(en)3]Cl(C2O4)Æ3H2O complex.
Figure 3 TGA/DTA curve of [Co(en)3]Cl(C2O4)Æ3H2O complex.
4 S. Jone Kirubavathy et al.Five membered ethylene diamine chelate rings have two
possible conformations known as D and K. When three such
chelates form a tris complex, the metal centre is chiral and will
have two possible enantiomeric conﬁgurations known as D andPlease cite this article in press as: Jone Kirubavathy, S. et al., Synthesis, characterizat
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simple symmetrical chelate ethylene diamine (en), a total of
eight isomers are possible: D(ddd) D(ddk) D(dkk) D(kkk)
K(ddd) K(ddk) K(dkk) and K(kkk). In the present crystal two
unusual conformers were found D (dkk) and K(ddk).
The water of hydration of the above said complex was car-
ried out using the laboratory method and was found to be 2.
The crystal structure shows three water molecules. This may
be due to a highly disordered water structure being indicative
of a dynamic equilibrium between small conglomerates and
free molecules.
4. Pharmacology
4.1. Antimicrobial activity
The investigated compound was tested against the bacteria
Escherichia coli, Bacillus subtilis, Staphylococcus aureus,
Klebsiella pneumoniae and fungi Mesodinium rubrum,ion, single crystal XRD, in vitro antimicrobial and cytotoxicity study of tris(eth-
2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.013
Figure 4 ORTEP diagram of [Co(en)3]Cl(C2O4)Æ3H2O complex.
Figure 5 Packing diagram of [Co(en)3]Cl(C2O4)Æ3H2O complex.
Table 4 Antifungal activity of the [Co(en)3]Cl(C2O4).3H2O
complex.
S. No. Organisms Zone of inhibition (mm)
Standard Complex
1 M. rubrum 17 23
2 A. niger 11 12
3 C. albicans 15 26
Table 2 Bond lengths [A] and angles [] for
[Co(en)3]Cl(C2O4)Æ3H2O.
Co(1)–N(5) 1.9538(15) N(5)–Co(1)–N(3) 91.93(7)
Co(1)–N(3) 1.9613(15) N(5)–Co(1)–N(2) 90.43(7)
Co(1)–N(2) 1.9615(15) N(3)–Co(1)–N(2) 175.17(7)
Co(1)–N(6) 1.9623(15) N(5)–Co(1)–N(6) 85.52(7)
Co(1)–N(1) 1.9650(16) N(3)–Co(1)–N(6) 90.06(7)
Co(1)–N(4) 1.9655(16) N(2)–Co(1)–N(6) 94.32(7)
O(2)–C(7) 1.254(2) N(5)–Co(1)–N(1) 174.06(7)
O(3)–C(7) 1.245(2) N(3)–Co(1)–N(1) 92.75(7)
O(4)–C(8) 1.252(2) N(2)–Co(1)–N(1) 85.17(7)
O(5)–C(8) 1.245(2) N(6)–Co(1)–N(1) 90.82(7)
N(1)–C(2) 1.487(2) N(5)–Co(1)–N(4) 91.14(7)
N(6)–C(5) 1.487(2) N(3)–Co(1)–N(4) 85.78(7)
N(3)–C(3) 1.482(3) N(2)–Co(1)–N(4) 89.97(7)
Co(1)–N(2) 1.9615(15) N(6)–Co(1)–N(4) 174.58(7)
Co(1)–N(6) 1.9623(15) N(1)–Co(1)–N(4) 92.84(7)
Co(1)–N(1) 1.9650(16) C(2)–N(1)–Co(1) 109.10(12)
Co(1)–N(4) 1.9655(16) C(5)–N(6)–Co(1) 109.52(12)
O(2)–C(7) 1.254(2) C(3)–N(3)–Co(1) 109.73(12)
O(3)–C(7) 1.245(2) C(6)–N(5)–Co(1) 109.68(12)
O(4)–C(8) 1.252(2) C(4)–N(4)–Co(1) 109.73(13)
O(5)–C(8) 1.245(2) C(1)–N(2)–Co(1) 110.53(12)
N(1)–C(2) 1.487(2) O(5)–C(8)–O(4) 124.63(18)
N(6)–C(5) 1.487(2) O(4)–C(8)–C(7) 117.25(16)
N(3)–C(3) 1.482(3) N(6)–C(5)–C(6) 117.93(16)
N(5)–C(6) 1.487(2) N(3)–C(3)–C(4) 106.97(15)
N(4)–C(4) 1.475(3) N(1)–C(2)–C(1) 108.67(17)
N(2)–C(1) 1.489(2) N(5)–C(6)–C(5) 106.82(15)
C(8)–C(7) 1.563(2) O(3)–C(7)–O(2) 106.95(15)
C(5)–C(6) 1.503(3) O(3)–C(7)–C(8) 126.50(17)
C(3)–C(4) 1.492(3) O(2)–C(7)–C(8) 117.09(16)
C(2)–C(1) 1.502(3) N(2)–C(1)–C(2) 116.30(16)
N(4)–C(4)–C(3) 107.45(15)
Table 3 Antibacterial activity of the [Co(en)3]Cl(C2O4).3H2O
complex.
S. No. Organisms Zone of Inhibition (mm)
Standard Complex
1 B. Subtilis 21 24
2 S. aureus 11 16
3 E. coli 17 19
4 K. pneumoniae 13 12
Cytotoxicity study of tris(ethylenediamine)cobalt(III)chloride oxalate trihydrate 5Aspergillus niger and Candida albicans. The minimum inhibi-
tory concentration (MIC) values of the complex against the
growth of microorganisms are summarized in Tables 3 and 4.
From Table 3 it is observed that the cobalt complex is more
active against all the test organisms especially Bacillus subtilis
and Staphylococcus aureus. This complex serves as a very good
anti-fungal agent against Mesodinium rubrum and Candida
albicans and shows a moderate activity against AspergillusPlease cite this article in press as: Jone Kirubavathy, S. et al., Synthesis, characterizat
ylenediamine)cobalt(III)chloride oxalate trihydrate. Arabian Journal of Chemistry (niger as shown in Table 4. Such increased activity of the
complexes can be explained with respect to Overtone’s concept
and Tweedy’s chelation theory. According to Overtone’s con-
cept of cell permeability, the lipid membrane that surrounds
the cell favours the passage of only the lipid-soluble materials
whose liposolubility is an important factor, which controls the
antimicrobial activity. On chelation, the polarity of the metal
ion is reduced to a great extent due to the overlap of the ligand
orbital and partial sharing of the positive charge of the metal
ion with donor groups. Further it increases the delocalization
of pi electrons over the whole chelate ring and enhances the
lipophilicity of the complexes. This increased lipophilicity
enhances the penetration of the complexes into lipid mem-
branes and blocking of the metal binding sites in the enzymes
of micro organisms. These complexes also disturb the respira-
tion process of the cell and thus block the synthesis of proteins,
which restricts further growth of the organisms (Munde et al.,
2012; Pelczar et al., 1996; Mane et al., 2001; Mishra and Singh,
1993; Dharmaraj et al., 2001).ion, single crystal XRD, in vitro antimicrobial and cytotoxicity study of tris(eth-
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a) 0.05 µM Concentration 
b) 50 µM Concentration 
Figure 6 Anticancer activity of [Co(en)3]Cl(C2O4)Æ3H2O
complex.
6 S. Jone Kirubavathy et al.4.2. Cytotoxic activity
To verify this bio-reductive activation mechanism under in-
vitro conditions, cyto-toxicity studies were carried out. More-
over, as the balance between the therapeutic potential and
toxic side effects of a compound is very important when eval-
uating its usefulness as a pharmacological drug, experiments
were designed to investigate the in-vitro cytotoxicity of the syn-
thesized cobalt complex against the MCF 7. Cytotoxicity was
determined by means of a colorimetric microculture MTT
assay, which measures the mitochondrial dehydrogenase activ-
ity as an indication of cell viability. It is evident that the num-
ber of cells decreased with an increase in the concentration of
the Co(III) complex (Fig. 6). The complex showed higher
potential antineoplastic activity which is evidenced by low
IC50 values (50% inhibitory concentration after exposure for
48 h. in MTT assay) of 55.85 lg/ml (Mosmann, 1983; Monks
et al., 1991).
The ability of the cobalt(III) complexes [Co(en)2(pyz)2]Br3
and [Co(en)2Cl2]Cl to induce cytotoxicity was investigated
and IC50 values for each derivative i.e. 110 and 90 lg/ml,
respectively were reported by Nagababu and co-workers
(Nagababu et al., 2009). In our present investigation, the
IC50 value of the title complex is 55.85 lg/ml which is more
toxic than the similar cobalt(III) ethylenediamine complexes
in the literature.
5. Conclusion
In conclusion, ethylenediamine cobalt complex has been syn-
thesized and the structure has been conﬁrmed by IR, elec-
tronic, molar conductance and TGA/DTA studies. ThePlease cite this article in press as: Jone Kirubavathy, S. et al., Synthesis, characterizat
ylenediamine)cobalt(III)chloride oxalate trihydrate. Arabian Journal of Chemistry (structure of the complex was further conﬁrmed from single
crystal XRD studies. The results of pharmacological evalua-
tion of this complex revealed that it possesses signiﬁcant
in vitro anti-microbial and anticancer activity. It is convincing
that this complex certainly holds great promise towards the
pursuit to discover a novel class of antimicrobial and antitu-
mour agents.
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